Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pet Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pet Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pet Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pet Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pet Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pet Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pet Vaccine development has been the leading industry trend of Pet Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pet Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Attenuated Live Vaccines,Conjugate Vaccines,Inactivated Vaccines,Subunit Vaccines,Toxoid Vaccines,DNA Vaccines,Recombinant Vaccines |
| By Application Outlook |
Canine,Avian,Feline, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer Healthcare,Vetoquinol S.A,Boehringer Ingelheim,Ceva,Eli Lilly,Heska Co.,Merck Animal Health,Merial (Sanofi),Virbac,Zoetis (Pfizer) |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska Co.
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Zoetis (Pfizer)
Pet Vaccine Market, By Type
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
Pet Vaccine Market, By Application
- Canine
- Avian
- Feline
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Pet Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pet Vaccine Market Size Growth Rate by Product
1.4.2 Attenuated Live Vaccines
1.4.3 Conjugate Vaccines
1.4.4 Inactivated Vaccines
1.4.5 Subunit Vaccines
1.4.6 Toxoid Vaccines
1.4.7 DNA Vaccines
1.4.8 Recombinant Vaccines
1.5 Market by End User
1.5.1 Global Pet Vaccine Market Size Growth Rate by End User
1.5.2 Canine
1.5.3 Avian
1.5.4 Feline
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pet Vaccine Market Size
2.1.1 Global Pet Vaccine Revenue 2014-2027
2.1.2 Global Pet Vaccine Sales 2014-2027
2.2 Pet Vaccine Growth Rate by Regions
2.2.1 Global Pet Vaccine Sales by Regions
2.2.2 Global Pet Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pet Vaccine Sales by Manufacturers
3.1.1 Pet Vaccine Sales by Manufacturers
3.1.2 Pet Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pet Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pet Vaccine Revenue by Manufacturers
3.2.1 Pet Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Pet Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Pet Vaccine Price by Manufacturers
3.4 Pet Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pet Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pet Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pet Vaccine Sales by Product
4.2 Global Pet Vaccine Revenue by Product
4.3 Pet Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pet Vaccine Breakdown Data by End User
6 North America
6.1 North America Pet Vaccine by Countries
6.1.1 North America Pet Vaccine Sales by Countries
6.1.2 North America Pet Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pet Vaccine by Product
6.3 North America Pet Vaccine by End User
7 Europe
7.1 Europe Pet Vaccine by Countries
7.1.1 Europe Pet Vaccine Sales by Countries
7.1.2 Europe Pet Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Vaccine by Product
7.3 Europe Pet Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Pet Vaccine by Countries
8.1.1 Asia Pacific Pet Vaccine Sales by Countries
8.1.2 Asia Pacific Pet Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pet Vaccine by Product
8.3 Asia Pacific Pet Vaccine by End User
9 Central & South America
9.1 Central & South America Pet Vaccine by Countries
9.1.1 Central & South America Pet Vaccine Sales by Countries
9.1.2 Central & South America Pet Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pet Vaccine by Product
9.3 Central & South America Pet Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Pet Vaccine by Countries
10.1.1 Middle East and Africa Pet Vaccine Sales by Countries
10.1.2 Middle East and Africa Pet Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pet Vaccine by Product
10.3 Middle East and Africa Pet Vaccine by End User
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Company Details
11.1.2 Company Business Overview
11.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer Healthcare Pet Vaccine Products Offered
11.1.5 Bayer Healthcare Recent Development
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Company Details
11.2.2 Company Business Overview
11.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Vetoquinol S.A Pet Vaccine Products Offered
11.2.5 Vetoquinol S.A Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Business Overview
11.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Boehringer Ingelheim Pet Vaccine Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Ceva
11.4.1 Ceva Company Details
11.4.2 Company Business Overview
11.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Ceva Pet Vaccine Products Offered
11.4.5 Ceva Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly Pet Vaccine Products Offered
11.5.5 Eli Lilly Recent Development
11.6 Heska Co.
11.6.1 Heska Co. Company Details
11.6.2 Company Business Overview
11.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Heska Co. Pet Vaccine Products Offered
11.6.5 Heska Co. Recent Development
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Details
11.7.2 Company Business Overview
11.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Animal Health Pet Vaccine Products Offered
11.7.5 Merck Animal Health Recent Development
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Company Details
11.8.2 Company Business Overview
11.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Merial (Sanofi) Pet Vaccine Products Offered
11.8.5 Merial (Sanofi) Recent Development
11.9 Virbac
11.9.1 Virbac Company Details
11.9.2 Company Business Overview
11.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Virbac Pet Vaccine Products Offered
11.9.5 Virbac Recent Development
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Company Details
11.10.2 Company Business Overview
11.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered
11.10.5 Zoetis (Pfizer) Recent Development
12 Future Forecast
12.1 Pet Vaccine Market Forecast by Regions
12.1.1 Global Pet Vaccine Sales Forecast by Regions 2020-2027
12.1.2 Global Pet Vaccine Revenue Forecast by Regions 2020-2027
12.2 Pet Vaccine Market Forecast by Product
12.2.1 Global Pet Vaccine Sales Forecast by Product 2020-2027
12.2.2 Global Pet Vaccine Revenue Forecast by Product 2020-2027
12.3 Pet Vaccine Market Forecast by End User
12.4 North America Pet Vaccine Forecast
12.5 Europe Pet Vaccine Forecast
12.6 Asia Pacific Pet Vaccine Forecast
12.7 Central & South America Pet Vaccine Forecast
12.8 Middle East and Africa Pet Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
